- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
318 results
1039 Exhibit: In hwan Baek et al, Evaluation of the Bioequivalence of Two Brands o...
Document
IPR2018-00943, No. 1039-34 Exhibit - In hwan Baek et al, Evaluation of the Bioequivalence of Two Brands of Naltrexone 50 mg Tablet in Healthy Volunteers (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1047 Exhibit: Food and Drug Administration, FDA PSYCHOPHARMACOLOGIC DR...
Document
IPR2018-00943, No. 1047-56 Exhibit - Food and Drug Administration, FDA PSYCHOPHARMACOLOGIC DRUGS ADVISORY COMMITTEE MEETING VIVITROL (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1013 Exhibit: TN Alim, et al, Tolerability Study of A Depot Form of Naltrexone Subst...
Document
IPR2018-00943, No. 1013-13 Exhibit - TN Alim, et al, Tolerability Study of A Depot Form of Naltrexone Substance Abusers (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1010 Exhibit: Sandra D Comer et al, Depot naltrexone long lasting antagonism of th...
Document
IPR2018-00943, No. 1010-57 Exhibit - Sandra D Comer et al, Depot naltrexone long lasting antagonism of the effects of heroin in humans (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1037 Exhibit: Bioequivalence, Center for Drug Evaluation and Research, Applicatio...
Document
IPR2018-00943, No. 1037-32 Exhibit - Bioequivalence, Center for Drug Evaluation and Research, Application Number (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1008 Exhibit: US Serial Number 11083,167, Amendment After Final, Oct 20, 2010
Document
IPR2018-00943, No. 1008-8 Exhibit - US Serial Number 11083,167, Amendment After Final, Oct 20, 2010 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1050 Exhibit: BA Johnson, Naltrexone long acting formulation in the treatment of al...
Document
IPR2018-00943, No. 1050-45 Exhibit - BA Johnson, Naltrexone long acting formulation in the treatment of alcohol dependence (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1056 Exhibit: LinkedIn profile of Steve Wright
Document
IPR2018-00943, No. 1056-51 Exhibit - LinkedIn profile of Steve Wright (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1041 Exhibit: Trademark Manual of Examining Procedure TMEP
Document
IPR2018-00943, No. 1041-36 Exhibit - Trademark Manual of Examining Procedure TMEP (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1012 Exhibit: CN Chiang et al, Clinical Evaluation of A Naltrexone Sustained Releas...
Document
IPR2018-00943, No. 1012-12 Exhibit - CN Chiang et al, Clinical Evaluation of A Naltrexone Sustained Release Preparation (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1018 Exhibit: US Patent No 6,264,987
Document
IPR2018-00943, No. 1018-16 Exhibit - US Patent No 6,264,987 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1036 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...
Document
IPR2018-00943, No. 1036-31 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1005 Exhibit: US Serial Number 11083,167, Office Action, Jan 6, 2010
Document
IPR2018-00943, No. 1005-5 Exhibit - US Serial Number 11083,167, Office Action, Jan 6, 2010 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1002 Exhibit: US Serial Number 11083,167, Office Action, May 5, 2009
Document
IPR2018-00943, No. 1002-2 Exhibit - US Serial Number 11083,167, Office Action, May 5, 2009 (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
1049 Exhibit: Rothenberg et al, Behavioral naltrexone therapy an integrated treatm...
Document
IPR2018-00943, No. 1049-44 Exhibit - Rothenberg et al, Behavioral naltrexone therapy an integrated treatment for opiate dependence (P.T.A.B. Apr. 20, 2018)
|
|
Cite Document
